Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Zygo Corporation
("Zygo" or the "Company") (Nasdaq:ZIGO) relating to the proposed
acquisition by AMETEK, Inc.
Click here to learn more about the investigation http://brodsky-smith.com/745-zigo-zygo-corporation.html,
or call 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Zygo shareholders will now receive
only $19.25 in cash for each share of Zygo stock they own. The
investigation concerns possible breaches of fiduciary duty and other
violations of tate law by the Board of Directors of Zygo for not acting
in the Company's shareholders' best interests in connection with the
sale process. The transaction may undervalue Zygo and will result in a
loss or no real gain for many long term holders of Zygo stock. For
example, the premium being paid to Zygo shareholders is below the
premium paid in comparable transactions and Zygo stock traded at $20.13
on May 2, 2012.
If you own shares of Zygo common stock and wish to discuss the legal
ramifications of the investigation, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may
contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky &
Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail
by visiting http://brodsky-smith.com/745-zigo-zygo-corporation.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and case
action lawsuits. The attorneys at Brodsky & Smith have been appointed by
numerous courts throughout the country to serve as lead counsel in class
actions and successfully recovered millions of dollars for our clients
and shareholders. Attorney advertising. Prior results do not guarantee a
[ Back To NFVZone's Homepage ]